K U 725 (Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg)

Pill imprint K U 725 has been identified as Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for K U 725

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg K U 725
Hydrochlorothiazide and moexipril hydrochloride
Imprint:
K U
725
Strength:
25 mg / 15 mg
Color:
Yellow
Size:
14.00 mm
Shape:
Figure eight-shape
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cobalt Laboratories Inc
National Drug Code (NDC):
16252-0614
Inactive Ingredients:
lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose
hypromellose
polyethylene glycol 6000
titanium dioxide
ferric oxide red

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)